These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24465408)

  • 1. Metformin: a potential therapeutic agent for recurrent colon cancer.
    Nangia-Makker P; Yu Y; Vasudevan A; Farhana L; Rajendra SG; Levi E; Majumdar AP
    PLoS One; 2014; 9(1):e84369. PubMed ID: 24465408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer.
    Vasudevan A; Yu Y; Banerjee S; Woods J; Farhana L; Rajendra SG; Patel A; Dyson G; Levi E; Maddipati KR; Majumdar AP; Nangia-Makker P
    Cancer Prev Res (Phila); 2014 Nov; 7(11):1138-48. PubMed ID: 25193342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.
    Yu Y; Sarkar FH; Majumdar AP
    Transl Oncol; 2013 Apr; 6(2):180-6. PubMed ID: 23544170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
    Yu Y; Nangia-Makker P; Farhana L; G Rajendra S; Levi E; Majumdar AP
    Mol Cancer; 2015 May; 14():98. PubMed ID: 25928322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells.
    Nautiyal J; Kanwar SS; Yu Y; Majumdar AP
    J Mol Signal; 2011 Jul; 6():7. PubMed ID: 21774804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21.
    Roy S; Yu Y; Padhye SB; Sarkar FH; Majumdar AP
    PLoS One; 2013; 8(7):e68543. PubMed ID: 23894315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Enhancement of Therapeutic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells and Nude Mice.
    Yip KL; Tsai TN; Yang IP; Miao ZF; Chen YC; Li CC; Su WC; Chang TK; Huang CW; Tsai HL; Yeh YS; Wang JY
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells.
    Kanwar SS; Yu Y; Nautiyal J; Patel BB; Padhye S; Sarkar FH; Majumdar AP
    Pharm Res; 2011 Apr; 28(4):827-38. PubMed ID: 21161336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
    Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutic diiminoquinone exhibits anticancer effects on human colorectal cancer cells in two-dimensional and three-dimensional
    Monzer A; Wakimian K; Ballout F; Al Bitar S; Yehya A; Kanso M; Saheb N; Tawil A; Doughan S; Hussein M; Mukherji D; Faraj W; Gali-Muhtasib H; Abou-Kheir W
    World J Gastroenterol; 2022 Sep; 28(33):4787-4811. PubMed ID: 36156922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin revert insulin-induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells.
    Liu C; Liu Q; Yan A; Chang H; Ding Y; Tao J; Qiao C
    Cancer Med; 2020 Jun; 9(11):3875-3884. PubMed ID: 32248666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation.
    Zaafar DK; Zaitone SA; Moustafa YM
    PLoS One; 2014; 9(6):e100562. PubMed ID: 24971882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
    Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
    Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells.
    Ju SY; Huang CY; Huang WC; Su Y
    Cell Death Dis; 2015 Jul; 6(7):e1801. PubMed ID: 26136074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer.
    Park JH; Kim YH; Park EH; Lee SJ; Kim H; Kim A; Lee SB; Shim S; Jang H; Myung JK; Park S; Lee SJ; Kim MJ
    Cancer Sci; 2019 Sep; 110(9):2834-2845. PubMed ID: 31278880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo.
    Moser C; Lang SA; Kainz S; Gaumann A; Fichtner-Feigl S; Koehl GE; Schlitt HJ; Geissler EK; Stoeltzing O
    Mol Cancer Ther; 2007 Nov; 6(11):2868-78. PubMed ID: 18025273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
    El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
    Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells.
    Genovese S; Epifano F; Preziuso F; Slater J; Nangia-Makker P; Majumdar APN; Fiorito S
    Biochem Biophys Res Commun; 2020 Jan; 522(1):95-99. PubMed ID: 31740005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres.
    Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
    Mol Cancer; 2010 Aug; 9():212. PubMed ID: 20691072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.
    Pandor A; Eggington S; Paisley S; Tappenden P; Sutcliffe P
    Health Technol Assess; 2006 Nov; 10(41):iii-iv, xi-xiv, 1-185. PubMed ID: 17049138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.